2014
Experiences of patients identifying with chronic Lyme disease in the healthcare system: a qualitative study
Ali A, Vitulano L, Lee R, Weiss TR, Colson ER. Experiences of patients identifying with chronic Lyme disease in the healthcare system: a qualitative study. BMC Primary Care 2014, 15: 79. PMID: 24885888, PMCID: PMC4012507, DOI: 10.1186/1471-2296-15-79.Peer-Reviewed Original ResearchConceptsChronic Lyme diseaseExperiences of patientsLyme diseaseHealth statusHealthcare providersHealthcare systemSubstantial clinical burdenBorrelia burgdorferi infectionHealth Belief ModelUnited States healthcare systemPersistent symptomsClinical burdenCAM therapiesDisease burdenDoctor-patient relationshipBurgdorferi infectionStates healthcare systemUnconventional therapiesCAM practitionersPatient experiencePatientsDiseaseClinical encountersHealthcare settingsBelief Model
1991
Zidovudine (AZT) for Treatment of Patients Infected With Human Immunodeficiency Virus Type 1: An Evaluation of Effectiveness in Clinical Practice
Colson E, Horwitz R, Bia F, Viscoli C. Zidovudine (AZT) for Treatment of Patients Infected With Human Immunodeficiency Virus Type 1: An Evaluation of Effectiveness in Clinical Practice. JAMA Internal Medicine 1991, 151: 709-713. DOI: 10.1001/archinte.1991.00400040061014.Peer-Reviewed Original ResearchZidovudine therapyDosage reductionAdverse outcomesHuman immunodeficiency virus type 1 (HIV-1) infectionClinical practiceHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Observational cohort studyHuman immunodeficiency virusTreatment of patientsType 1 infectionVirus type 1Zidovudine dosageCohort studyMost patientsImmunodeficiency virusBaseline cytopeniasTreatment outcomesPatterns of usePatientsTherapyType 1Dosage changesMonths